261 related articles for article (PubMed ID: 26456105)
61. Fabry pedigree analysis: A successful program for targeted genetic approach.
Rozenfeld PA; Masllorens FM; Roa N; Rodriguez F; Bonnano M; Yvorra C; Ceci R
Mol Genet Genomic Med; 2019 Jul; 7(7):e00794. PubMed ID: 31169365
[TBL] [Abstract][Full Text] [Related]
62. Fabry disease due to D313Y and novel GLA mutations.
Koulousios K; Stylianou K; Pateinakis P; Zamanakou M; Loules G; Manou E; Kyriklidou P; Katsinas C; Ouzouni A; Kyriazis J; Speletas M; Germenis AE
BMJ Open; 2017 Oct; 7(10):e017098. PubMed ID: 28988177
[TBL] [Abstract][Full Text] [Related]
63. Female Fabry disease patients and X-chromosome inactivation.
Juchniewicz P; Kloska A; Tylki-Szymańska A; Jakóbkiewicz-Banecka J; Węgrzyn G; Moskot M; Gabig-Cimińska M; Piotrowska E
Gene; 2018 Jan; 641():259-264. PubMed ID: 29079200
[TBL] [Abstract][Full Text] [Related]
64. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
[TBL] [Abstract][Full Text] [Related]
65. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes.
Adalsteinsdottir B; Palsson R; Desnick RJ; Gardarsdottir M; Teekakirikul P; Maron M; Appelbaum E; Neisius U; Maron BJ; Burke MA; Chen B; Pagant S; Madsen CV; Danielsen R; Arngrimsson R; Feldt-Rasmussen U; Seidman JG; Seidman CE; Gunnarsson GT
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28798024
[TBL] [Abstract][Full Text] [Related]
66. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
[TBL] [Abstract][Full Text] [Related]
67. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
[TBL] [Abstract][Full Text] [Related]
68. High variability of Fabry disease manifestations in an extended Italian family.
Cammarata G; Fatuzzo P; Rodolico MS; Colomba P; Sicurella L; Iemolo F; Zizzo C; Alessandro R; Bartolotta C; Duro G; Monte I
Biomed Res Int; 2015; 2015():504784. PubMed ID: 25977923
[TBL] [Abstract][Full Text] [Related]
69. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.
Ishii S; Chang HH; Kawasaki K; Yasuda K; Wu HL; Garman SC; Fan JQ
Biochem J; 2007 Sep; 406(2):285-95. PubMed ID: 17555407
[TBL] [Abstract][Full Text] [Related]
70. Parkinson's Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees.
Gago MF; Azevedo O; Guimarães A; Teresa Vide A; Lamas NJ; Oliveira TG; Gaspar P; Bicho E; Miltenberger-Miltenyi G; Ferreira J; Sousa N
J Parkinsons Dis; 2020; 10(1):141-152. PubMed ID: 31594250
[TBL] [Abstract][Full Text] [Related]
71. X-chromosome inactivation in female patients with Fabry disease.
Echevarria L; Benistan K; Toussaint A; Dubourg O; Hagege AA; Eladari D; Jabbour F; Beldjord C; De Mazancourt P; Germain DP
Clin Genet; 2016 Jan; 89(1):44-54. PubMed ID: 25974833
[TBL] [Abstract][Full Text] [Related]
72. First phenotypic description of a female patient with c.610 T > C variant of GLA: a renal-predominant presentation of Fabry disease.
Greillier S; Daniel L; Caillaud C; Dussol B; Touchard G; Goujon JM; Jourde-Chiche N; Bobot M
BMC Med Genet; 2020 Jun; 21(1):137. PubMed ID: 32590976
[TBL] [Abstract][Full Text] [Related]
73. Role of the p.E66Q variant of GLA in the progression of chronic kidney disease.
Watanabe H; Goto S; Miyashita A; Maruyama H; Wakasugi M; Yokoseki A; Kuwano R; Narita I
Clin Exp Nephrol; 2015 Apr; 19(2):225-30. PubMed ID: 24718812
[TBL] [Abstract][Full Text] [Related]
74. De novo mutation in a male patient with Fabry disease: a case report.
Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
[TBL] [Abstract][Full Text] [Related]
75. Generation of a CRISPR/Cas9-corrected-hiPSC line (DDLABi001-A) from Fabry disease (FD)-derived iPSCs having α-galactosidase (GLA) gene mutation (c.803_806del).
Choi JB; Seo D; Do HS; Han YM
Stem Cell Res; 2023 Feb; 66():103001. PubMed ID: 36516658
[TBL] [Abstract][Full Text] [Related]
76. Genotype⁻Phenotype Correlation in a New Fabry-Disease-Causing Mutation.
Čerkauskaitė A; Čerkauskienė R; Miglinas M; Laurinavičius A; Ding C; Rolfs A; Vencevičienė L; Barysienė J; Kazėnaitė E; Sadauskienė E
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31067829
[No Abstract] [Full Text] [Related]
77.
Li P; Xi Y; Zhang Y; Samad A; Lan W; Wu Y; Zhao J; Chen G; Wu C; Xiong Q
Cells; 2024 Mar; 13(5):. PubMed ID: 38474401
[TBL] [Abstract][Full Text] [Related]
78. Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease.
Pan X; Ouyang Y; Wang Z; Ren H; Shen P; Wang W; Xu Y; Ni L; Yu X; Chen X; Zhang W; Yang L; Li X; Xu J; Chen N
PLoS One; 2016; 11(8):e0161330. PubMed ID: 27560961
[TBL] [Abstract][Full Text] [Related]
79. Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease.
Fujii H; Kono K; Goto S; Onishi T; Kawai H; Hirata K; Hattori K; Nakamura K; Endo F; Fukagawa M
Am J Nephrol; 2009; 30(6):527-35. PubMed ID: 19844084
[TBL] [Abstract][Full Text] [Related]
80. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
